MAPK3 and neoplasm: As a non-tyrosine-kinase receptor, NRP1 can moderately increase the expression of the phosphorylation of Erk1/2, Akt, and P38MAPK to promote tumor cell proliferation and metastasis, as well as to curb the apoptosis and immune responses.